[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2390428A1 - Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments - Google Patents

Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments

Info

Publication number
FR2390428A1
FR2390428A1 FR7812933A FR7812933A FR2390428A1 FR 2390428 A1 FR2390428 A1 FR 2390428A1 FR 7812933 A FR7812933 A FR 7812933A FR 7812933 A FR7812933 A FR 7812933A FR 2390428 A1 FR2390428 A1 FR 2390428A1
Authority
FR
France
Prior art keywords
preparation
application
medicinal products
polyene compounds
new polyene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7812933A
Other languages
English (en)
Other versions
FR2390428B1 (fr
Inventor
Peter Loeliger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2390428A1 publication Critical patent/FR2390428A1/fr
Application granted granted Critical
Publication of FR2390428B1 publication Critical patent/FR2390428B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nouveaux composés polyéniques, leur préparation et leur application en tant que médicaments. Les composés de l'invention répondent à la formule générale I :
FR7812933A 1977-05-04 1978-05-02 Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments Granted FR2390428A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77254A LU77254A1 (fr) 1977-05-04 1977-05-04

Publications (2)

Publication Number Publication Date
FR2390428A1 true FR2390428A1 (fr) 1978-12-08
FR2390428B1 FR2390428B1 (fr) 1983-03-04

Family

ID=19728555

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7812933A Granted FR2390428A1 (fr) 1977-05-04 1978-05-02 Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments

Country Status (32)

Country Link
US (1) US4193931A (fr)
JP (1) JPS53137940A (fr)
AR (1) AR220704A1 (fr)
AT (1) AT356647B (fr)
AU (1) AU522598B2 (fr)
BE (1) BE866651A (fr)
BR (1) BR7802807A (fr)
CA (1) CA1114830A (fr)
CH (2) CH641755A5 (fr)
CS (1) CS214853B2 (fr)
CU (1) CU21105A (fr)
DE (1) DE2819213A1 (fr)
DK (1) DK155730C (fr)
ES (2) ES469394A1 (fr)
FI (1) FI66587C (fr)
FR (1) FR2390428A1 (fr)
GB (2) GB1600915A (fr)
GR (1) GR74426B (fr)
HU (1) HU183088B (fr)
IE (1) IE46946B1 (fr)
IL (2) IL54590A (fr)
IT (1) IT1096278B (fr)
LU (1) LU77254A1 (fr)
MC (1) MC1193A1 (fr)
MY (1) MY8500250A (fr)
NL (1) NL7804773A (fr)
NO (1) NO148290C (fr)
NZ (1) NZ187114A (fr)
PH (1) PH14216A (fr)
PT (1) PT67988B (fr)
SE (1) SE436644B (fr)
ZA (1) ZA782415B (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556348A1 (fr) * 1983-12-08 1985-06-14 Hoffmann La Roche Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis
FR2719041A1 (fr) * 1994-04-26 1995-10-27 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
WO1997012853A1 (fr) * 1995-10-06 1997-04-10 Ligand Pharmaceuticals Incorporated Modulateurs rxr selectifs pour les dimeres et leurs methodes d'utilisation
WO1998007716A2 (fr) * 1996-08-23 1998-02-26 The Board Of Regents For Oklahoma State University Agents anticancereux hetero-arotinoides possedant une specificite en matiere de recepteurs et une activite de tgase
EP0826657A1 (fr) * 1996-09-02 1998-03-04 Centre International De Recherches Dermatologiques Galderma, ( Cird Galderma) Nouveaux composés modulateurs des récepteurs hormonaux, les compositions les comprenant et leur utilisation en thérapie
FR2768731A1 (fr) * 1997-09-25 1999-03-26 Cird Galderma Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
US6534545B1 (en) 1997-09-25 2003-03-18 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
US7098025B1 (en) 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
WO2020021477A3 (fr) * 2018-07-27 2020-05-07 Johnson & Johnson Vision Care, Inc. Compositions et procédés de traitement de l'oeil

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216312A (en) 1978-08-24 1980-08-05 Hoffmann-La Roche Inc. Furyl substituted polyenes
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
CH651007A5 (de) * 1982-06-24 1985-08-30 Hoffmann La Roche Polyenverbindungen.
DK158947C (da) * 1982-07-06 1991-01-21 Hoffmann La Roche Tetrahydronaphthalin-,benzofuran- og benzothiophenderivater, fremstilling og anvendelse deraf samt rodenticid indeholdende saadanne derivater
US4529600A (en) * 1982-09-09 1985-07-16 Sri International Pentadeuterioretinoids
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
US4464389A (en) * 1982-10-20 1984-08-07 Sri International Esters of retinoic acid and pentaerythritol and monobenzal acetals thereof
US4539154A (en) * 1983-06-15 1985-09-03 Hoffmann-La Roche Inc. Polyene compounds
US4783549A (en) * 1984-09-05 1988-11-08 L'oreal Benzonorbornene derivatives, processes for their preparation and medicinal and cosmetic compositions containing them
FR2580277B1 (fr) * 1985-04-15 1988-06-10 Oreal Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
US5250562A (en) * 1988-02-24 1993-10-05 Hoffmann-La Roche Inc. Stilbene derivatives
US5248696A (en) * 1991-04-18 1993-09-28 World Research Institute For Science And Technology, Inc. Composition and method for treating tumors
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
CA2129773C (fr) 1993-09-02 2007-05-01 Michael Klaus Derives d'acides carboxyliques aromatiques
CA2208981C (fr) * 1994-12-30 2008-08-26 Ligand Pharmaceuticals Incorporated Nouveaux composes de retinoide trienoique et methodes d'utilisation
US6112489A (en) * 1995-12-12 2000-09-05 Monotech International, Inc. Monocoque concrete structures
AU4676999A (en) * 1998-06-12 1999-12-30 Ligand Pharmaceuticals, Inc. Treatment of anti-estrogen resistant breast cancer using rxr modulators
US6667313B1 (en) 1999-08-27 2003-12-23 Ligand Pharmaceuticals Inc. 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators
ATE323709T1 (de) 1999-08-27 2006-05-15 Ligand Pharm Inc Androgenrezeptor-modulatorverbindungen und verfahren
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
WO2001019770A2 (fr) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Modulateurs rxr a profil pharmacologique ameliore
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
CA2506504A1 (fr) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Traitement de cellules pulmonaires avec des inhibiteurs d'histone deacetylase
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
WO2006052916A2 (fr) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Inc. Inhibiteurs d'histone deacetylase
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (fr) * 2010-12-09 2012-06-14 University Of Durham Rétinoïdes synthétiques pour le contrôle de la différenciation des cellules
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas
KR102699198B1 (ko) * 2017-09-28 2024-08-27 존슨 앤드 존슨 컨수머 인코포레이티드 화장 조성물 및 피부 치료 방법
US10966948B2 (en) 2019-07-23 2021-04-06 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11197841B2 (en) 2019-07-23 2021-12-14 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye
US11969454B2 (en) 2019-11-19 2024-04-30 Johnson & Johnson Surgical Vision, Inc. Compositions and methods for treating the eye

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452085A (en) * 1966-02-11 1969-06-24 Carbo Erba Spa Alpha-(5-indanyl)-butyric acid
US3781314A (en) * 1971-07-14 1973-12-25 Hoffmann La Roche Polyene compounds
FR2239996A1 (fr) * 1973-08-10 1975-03-07 Hoffmann La Roche
FR2248831A1 (fr) * 1973-10-30 1975-05-23 Sandoz Sa
FR2260334A1 (en) * 1974-02-07 1975-09-05 Hexachimie Indanes e.g. (5-(1,3-dimethyl)indanyl) acetic acid, alcohols and amine - used as antiinflammatory and analgesic agents
US3931257A (en) * 1973-08-24 1976-01-06 Hoffmann-La Roche Inc. Polyene compounds
FR2276035A1 (fr) * 1974-06-28 1976-01-23 Lipha Nouveaux derives de l'indane
FR2285863A1 (fr) * 1974-09-26 1976-04-23 Hoffmann La Roche Nouveaux composes polyeniques utiles pour le traitement de neoplasies malignes et benignes, ainsi que leur procede de preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793108A (fr) * 1971-12-22 1973-06-21 Hoffmann La Roche Derives polyeniques
FR2235679B1 (fr) * 1973-07-02 1978-07-21 Takeda Chemical Industries Ltd
US4054589A (en) * 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452085A (en) * 1966-02-11 1969-06-24 Carbo Erba Spa Alpha-(5-indanyl)-butyric acid
US3781314A (en) * 1971-07-14 1973-12-25 Hoffmann La Roche Polyene compounds
FR2239996A1 (fr) * 1973-08-10 1975-03-07 Hoffmann La Roche
US3931257A (en) * 1973-08-24 1976-01-06 Hoffmann-La Roche Inc. Polyene compounds
FR2248831A1 (fr) * 1973-10-30 1975-05-23 Sandoz Sa
FR2260334A1 (en) * 1974-02-07 1975-09-05 Hexachimie Indanes e.g. (5-(1,3-dimethyl)indanyl) acetic acid, alcohols and amine - used as antiinflammatory and analgesic agents
FR2276035A1 (fr) * 1974-06-28 1976-01-23 Lipha Nouveaux derives de l'indane
FR2285863A1 (fr) * 1974-09-26 1976-04-23 Hoffmann La Roche Nouveaux composes polyeniques utiles pour le traitement de neoplasies malignes et benignes, ainsi que leur procede de preparation

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556348A1 (fr) * 1983-12-08 1985-06-14 Hoffmann La Roche Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5705167A (en) * 1994-04-26 1998-01-06 Centre International De Recherches Dermatologiques Galderma Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof
FR2719041A1 (fr) * 1994-04-26 1995-10-27 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
USRE37947E1 (en) * 1994-04-26 2002-12-31 Centre International De Recherches Dermatologiques Galderma Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof
EP0679628A1 (fr) * 1994-04-26 1995-11-02 Centre International De Recherches Dermatologiques Galderma (C.I.R.D. Galderma) Composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations
US7115728B1 (en) 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1997012853A1 (fr) * 1995-10-06 1997-04-10 Ligand Pharmaceuticals Incorporated Modulateurs rxr selectifs pour les dimeres et leurs methodes d'utilisation
EP1336600A2 (fr) * 1995-10-06 2003-08-20 Ligand Pharmaceuticals Incorporated Modulateurs RXR sélectifs pour les dimères et leurs méthodes d'utilisation
US6545049B1 (en) 1995-10-06 2003-04-08 Ligand Pharmaceuticals Incorporated Dimer-selective RXR modulators and methods for their use
EP1336600A3 (fr) * 1995-10-06 2004-07-07 Ligand Pharmaceuticals Incorporated Modulateurs RXR sélectifs pour les dimères et leurs méthodes d'utilisation
WO1998007716A3 (fr) * 1996-08-23 1998-03-26 Univ Oklahoma State Agents anticancereux hetero-arotinoides possedant une specificite en matiere de recepteurs et une activite de tgase
WO1998007716A2 (fr) * 1996-08-23 1998-02-26 The Board Of Regents For Oklahoma State University Agents anticancereux hetero-arotinoides possedant une specificite en matiere de recepteurs et une activite de tgase
EP0826657A1 (fr) * 1996-09-02 1998-03-04 Centre International De Recherches Dermatologiques Galderma, ( Cird Galderma) Nouveaux composés modulateurs des récepteurs hormonaux, les compositions les comprenant et leur utilisation en thérapie
FR2752837A1 (fr) * 1996-09-02 1998-03-06 Cird Galderma Nouveaux composes modulateurs des recepteurs hormonaux, les compositions les comprenant et leur utilisation en therapie
US5910508A (en) * 1996-09-02 1999-06-08 Centre International De Recherches Dermatologiques Galderma Polycyclic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof
US7098025B1 (en) 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
US6180674B1 (en) 1997-09-25 2001-01-30 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1, 1- dimethylindane and their use in human and veterinary medicine and in cosmetics
US6642273B2 (en) 1997-09-25 2003-11-04 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and in cosmetics
US6534545B1 (en) 1997-09-25 2003-03-18 Galderma Research & Development Unsaturated derivatives at the 4-position of 6-tert-butyl-1,1-dimethylindane and their use in human and veterinary medicine and cosmetics
EP0905118A1 (fr) * 1997-09-25 1999-03-31 Galderma Research & Development, S.N.C. Dérivés insaturés en position 4 du 6-tert-butyl-1,1-diméthylindane et leur utilisation en médicine humaine ou vétérinaire ainsi qu'en cosmétique
FR2768731A1 (fr) * 1997-09-25 1999-03-26 Cird Galderma Derives insatures en position -4 du 6-tert-butyl-1,1- dimethylindane et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
US6586460B1 (en) 2001-04-02 2003-07-01 The Board Of Regents For Oklahoma State University Heteroarotinoids containing urea or thiourea linker
WO2020021477A3 (fr) * 2018-07-27 2020-05-07 Johnson & Johnson Vision Care, Inc. Compositions et procédés de traitement de l'oeil

Also Published As

Publication number Publication date
ZA782415B (en) 1979-04-25
IE780864L (en) 1978-11-04
IL61697A0 (en) 1981-01-30
NO781586L (no) 1978-11-07
MC1193A1 (fr) 1979-02-23
NZ187114A (en) 1980-11-14
AT356647B (de) 1980-05-12
IE46946B1 (en) 1983-11-16
GR74426B (fr) 1984-06-28
DK155730C (da) 1989-10-02
DE2819213A1 (de) 1978-11-16
PH14216A (en) 1981-04-02
DK155730B (da) 1989-05-08
ATA320478A (de) 1979-10-15
GB1600915A (en) 1981-10-21
CH641755A5 (de) 1984-03-15
FI66587B (fi) 1984-07-31
JPS53137940A (en) 1978-12-01
FI781227A (fi) 1978-11-05
CU21105A (es) 1981-12-04
ES469394A1 (es) 1979-02-01
NO148290B (no) 1983-06-06
DE2819213C2 (fr) 1987-09-24
JPS6332777B2 (fr) 1988-07-01
NO148290C (no) 1983-09-14
DK195378A (da) 1978-11-05
ES475240A1 (es) 1979-05-16
LU77254A1 (fr) 1979-01-18
IL54590A0 (en) 1978-07-31
BE866651A (fr) 1978-11-03
US4193931A (en) 1980-03-18
IT1096278B (it) 1985-08-26
SE7805136L (sv) 1978-11-05
IT7823003A0 (it) 1978-05-04
FI66587C (fi) 1984-11-12
AU3576278A (en) 1979-11-08
BR7802807A (pt) 1979-01-02
CS214853B2 (en) 1982-06-25
SE436644B (sv) 1985-01-14
CA1114830A (fr) 1981-12-22
AR220704A1 (es) 1980-11-28
GB1600914A (en) 1981-10-21
FR2390428B1 (fr) 1983-03-04
MY8500250A (en) 1985-12-31
AU522598B2 (en) 1982-06-17
NL7804773A (nl) 1978-11-07
PT67988B (en) 1980-05-05
HU183088B (en) 1984-04-28
CH642380A5 (de) 1984-04-13
IL54590A (en) 1982-02-28
PT67988A (en) 1978-06-01

Similar Documents

Publication Publication Date Title
FR2390428A1 (fr) Nouveaux composes polyeniques, leur preparation et leur application en tant que medicaments
FR2367053A1 (fr) Nouveaux derives de phenoxy-amino-propanol, leur preparation et leur application en tant que medicaments
FR2400512A1 (fr) Nouveaux nitro-imidazoles, leur preparation et leur application en tant que medicaments
FR2398748A1 (fr) Nouveaux derives d'imidazoquinazoline, leur preparation et leur application en tant que medicaments
FR2422643A1 (fr) Nouveaux derives d'imidazolidine, leur preparation et leur application comme medicaments
FR2422620A1 (fr) Derives du stilbene, leur preparation et leur application en tant que medicaments
FR2432511A1 (fr) Derives triazoliques, leur preparation et leur application en tant que medicaments
FR2360601A1 (fr) Nouveaux derives d'acides phosphoneux, leur preparation et leur application en tant que medicaments
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
FR2355007A1 (fr) (3-alcoyle inferieur-amino-2-r, 10 propoxy pyridines substituees, leur preparation et leur application en tant que medicaments
FR2415103A1 (fr) Acides et derives d'acides 4-pyridone-3-carboxyliques, leur preparation et leur application en tant que medicaments
FR2398058A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2378014A1 (fr) Nouveaux derives aminoalcoxyphenyles, leur preparation et leur utilisation en tant que medicaments
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2355021A1 (fr) Nouveaux derives d'imidazothiazine et leur application en tant que medicaments
FR2379538A1 (fr) Nouveaux derives d'oxadiazolopyrimidine, leur preparation et leur application en tant que medicaments
FR2355012A1 (fr) Nouveaux derives de dihydro- et tetrahydro-iminothiazine, et leur application en tant que medicaments
FR2370745A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2401160A1 (fr) Nouveaux derives d'esters de vincaminol, leur preparation et leur application en tant que medicaments
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
FR2367061A1 (fr) Nouveaux derives de l'acide 13-thiaprostanoique, leur preparation et leur application en tant que medicaments
FR2432506A1 (fr) Nouveaux derives de 6-methoxy-2-acetylnaphtalene oxime, leur preparation et leur application en tant que medicaments
FR2422647A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments
FR2396748A1 (fr) Nouveaux derives de prostaglandine, leur preparation et leur application en tant que medicaments
FR2384767A1 (fr) Nouveaux derives d'acides benzo-heteroxyclylglyoxyliques, leur preparation et leur application en tant que medicament

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse